机构:[a]Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, China[b]Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China, China[c]Key Unit of Modulating Liver to Treat Hyperlipemia SATCM (State Administration of Traditional Chinese Medicine), China[d]Institute of Chinese Medicinal Sciences, Guangdong Pharmaceutical University, Guangdong TCM Key Laboratory against Metabolic Diseases, China[e]Department of Cardiovascular Diseases, the First Affiliated Hospital of Guangdong Pharmaceutical University, China
grants from the National Natural Science
Funds, China (No. 81530102, 2016),National key R & D plan
“Research on modernization of traditional Chinese medicine”
(2018YFC1704200) and the construction of the international cooperation
base of Guangdong Provincial Science and Technology Department;
the construction of the international cooperation base for the prevention
and treatment of metabolic diseases (2016B050501003), Guangdong
Provincial TCM Administration Department Grant (20151269), Innovative
Strong School Project of Guangdong Pharmaceutical University
(2018KQNCX130), Basic and Applied Basic Research fund of Guangdong
Province (2019A1515110123), The Medical Science and Technology
Research Fund of Guangdong Province (A2019531).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类|2 区医学
小类|2 区药学3 区医学:研究与实验
最新[2025]版:
大类|2 区医学
小类|2 区医学:研究与实验2 区药学
第一作者:
第一作者机构:[a]Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, China[d]Institute of Chinese Medicinal Sciences, Guangdong Pharmaceutical University, Guangdong TCM Key Laboratory against Metabolic Diseases, China
共同第一作者:
通讯作者:
通讯机构:[a]Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, China[b]Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China, China[c]Key Unit of Modulating Liver to Treat Hyperlipemia SATCM (State Administration of Traditional Chinese Medicine), China[d]Institute of Chinese Medicinal Sciences, Guangdong Pharmaceutical University, Guangdong TCM Key Laboratory against Metabolic Diseases, China[*1]Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, The Institute of Chinese Medicinal Sciences, Guangdong Pharmaceutical University, Guangzhou 510006, China
推荐引用方式(GB/T 7714):
Lixia Song,Dongxing Zhang,Caijuan Guo,et al.The traditional Chinese medicine formula Fufang-Zhenzhu-Tiaozhi protects myocardia from injury in diabetic minipigs with coronary heart disease.[J].BIOMEDICINE & PHARMACOTHERAPY.2021,137:111343.doi:10.1016/j.biopha.2021.111343.
APA:
Lixia Song,Dongxing Zhang,Caijuan Guo,Zhanhui Gu,Lexun Wang...&Jiao Guo.(2021).The traditional Chinese medicine formula Fufang-Zhenzhu-Tiaozhi protects myocardia from injury in diabetic minipigs with coronary heart disease..BIOMEDICINE & PHARMACOTHERAPY,137,
MLA:
Lixia Song,et al."The traditional Chinese medicine formula Fufang-Zhenzhu-Tiaozhi protects myocardia from injury in diabetic minipigs with coronary heart disease.".BIOMEDICINE & PHARMACOTHERAPY 137.(2021):111343